Combination therapy of gastric carcinoma with radiation and chemotherapy.

Publisher Website
Google Scholar
Abstract
The concurrent combination therapy of radiation and chemotherapy was performed in 134 cases of stomach cancer. Radiation response of tumor was remarkable in 35 (37%) of 95 cases, irradiated with more than 5000 rad. Yearly survival rates in 81 cases, in which the scheduled curative treatment was completed, were 63% in yr 1, 31% in yr 2, 21% in yr 3, 17% in yr 4 and 13% in yr 5. These rates were intimately correlated to tumor size and cancer type. This combination therapy accompanied some fatal complications in a few percent. This combination therapy should be valuable in prolonging the life of patients with gastric cancer, and the curable indications for this treatment should be T1-T3: M0 cases with radio-responsive tumor.

This publication has 1 reference indexed in Scilit: